Expanded age range for 9-valent HPV vaccine : Work Group plans and policy considerations

Markowitz, Lauri E.

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Expanded age range for 9-valent HPV vaccine : Work Group plans and policy considerations

October 25, 2018
By Markowitz, Lauri E.
Series: ACIP meeting Human Papillomavirus (HPV) Vaccines Update

[PDF-289.92 KB]

English

Details Related Documents You May Also Like

Details:

Personal Author:

Markowitz, Lauri E.
Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
Conference Authors:

United States. Advisory Committee on Immunization Practices. Meeting (2018 October 24 : Atlanta, GA)
Subjects:

[+]

Papillomavirus Vaccines
Series:

ACIP meeting Human Papillomavirus (HPV) Vaccines Update
Document Type:

Presentation
Name as Subject:

ACIP meeting: 2018 Oct ; ACIP meeting: 2018 Oct

ACIP meeting: 2018 Oct ; ACIP meeting: 2018 Oct Less -
Genre:

Conference Publications
Volume:

201803
Issue:

010705
Collection(s):

Advisory Committee on Immunization Practices (ACIP)
Main Document Checksum:

[+]

urn:sha256:70a0cf785c31dbce0d773d5ba7a91381e7b28b6582ad0401db44e9430edd091b
Download URL:

https://stacks.cdc.gov/view/cdc/61464/cdc_61464_DS1.pdf
File Type:

No Additional Files

More +

Expanded age range for 9-valent HPV vaccine : Work Group plans and policy considerations

Details:

Supporting Files

Related Documents

You May Also Like